| Advanced Enzyme Technologies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540025 |
NSE Symbol : ADVENZYMES |
P/E(TTM) : 36.83 |
|
ISIN Demat : INE837H01020 |
Div & Yield% : 1.41 |
EPS(TTM) : 9.82 |
|
Book Value(₹) : 53.82 |
Market Cap(₹Cr) : 4,046.72 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 77.38 | 85.96 | 92.40 | 91.14 | 96.58 | 85.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 77.38 | 85.96 | 92.40 | 91.14 | 96.58 | 85.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.66 | 53.88 | 3.21 | 3.57 | 0.79 | 51.25 |
| Total Income | 79.03 | 139.83 | 95.61 | 94.71 | 97.36 | 136.60 |
| Total Expenditure | 63.85 | 65.04 | 82.11 | 66.59 | 69.96 | 60.57 |
| PBIDT | 15.18 | 74.80 | 13.51 | 28.11 | 27.40 | 76.03 |
| Interest | 0.08 | 0.02 | 0.05 | 0.04 | 0.03 | 0.04 |
| PBDT | 15.11 | 74.78 | 13.46 | 28.07 | 27.37 | 75.99 |
| Depreciation | 2.78 | 2.62 | 3.07 | 2.72 | 2.61 | 2.51 |
| Tax | 3.07 | 4.95 | 7.54 | 6.74 | 6.62 | 6.07 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.13 | 0.15 | -0.28 | -0.50 | -0.23 | -0.07 |
| Reported Profit After Tax | 9.13 | 67.06 | 3.14 | 19.12 | 18.38 | 67.49 |
| Extra-ordinary Items | 0.00 | 0.00 | -11.41 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 9.13 | 67.06 | 14.55 | 19.12 | 18.38 | 67.49 |
| EPS (Unit Curr.) | 0.82 | 6.00 | 0.28 | 1.71 | 1.64 | 6.04 |
| EPS (Adj) (Unit Curr.) | 0.82 | 6.00 | 0.28 | 1.71 | 1.64 | 6.04 |
| Calculated EPS (Unit Curr.) | 0.82 | 6.00 | 0.28 | 1.71 | 1.64 | 6.04 |
| Calculated EPS (Adj) (Unit Curr.) | 0.82 | 6.00 | 0.28 | 1.71 | 1.64 | 6.04 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.26 | 23.99 | 1.12 | 6.84 | 6.57 | 24.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.26 | 23.99 | 1.12 | 6.84 | 6.57 | 24.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 200.00 | 200.00 | 0.00 | 0.00 | 200.00 | 200.00 |
| Equity | 22.37 | 22.37 | 22.37 | 22.37 | 22.37 | 22.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.62 | 87.02 | 14.62 | 30.84 | 28.37 | 89.08 |
| PBDTM(%) | 19.53 | 86.99 | 14.57 | 30.80 | 28.34 | 89.03 |
| PATM(%) | 11.80 | 78.01 | 3.40 | 20.98 | 19.03 | 79.07 |